Caitong International Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,382
Closed -$81.9K – 3348
2026
Q1
$81.9K Buy
1,382
+808
+141% +$52.4K 0.02% 639
2025
Q4
$35.4K Buy
574
+236
+70% +$14.4K 0.01% 833
2025
Q3
$21.1K Buy
338
+8
+2% +$557 0.01% 676
2025
Q2
$26.4K Buy
330
+250
+313% +$20.9K 0.02% 434
2025
Q1
$6.88K Buy
+80
New +$6.56K 0.01% 947

Other funds holding PBH

Caitong International Asset Management's PBH Position: Q2 2026 in Review

Caitong International Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 1,382 shares — an estimated $81.9K sold.

Caitong International Asset Management first reported a position in PBH in Q1 2025 and held it in 5 quarters. The position peaked at $81.9K in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Caitong International Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,382 Prestige Consumer Healthcare shares in Q2 2026, an estimated $81.9K.
  • Caitong International Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2025 and held it in 5 quarters.
  • Caitong International Asset Management's Prestige Consumer Healthcare position peaked at $81.9K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.